Current Report Filing (8-k)
April 30 2021 - 4:13PM
Edgar (US Regulatory)
PERKINELMER INC false 0000031791 0000031791 2021-04-27 2021-04-27 0000031791 us-gaap:CommonStockMember 2021-04-27 2021-04-27 0000031791 us-gaap:DeferrableNotesMember 2021-04-27 2021-04-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 27, 2021
PerkinElmer, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
Massachusetts
|
|
001-05075
|
|
04-2052042
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
940 Winter Street, Waltham, Massachusetts
|
|
02451
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code: (781) 663-6900
Not applicable.
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol
|
|
Name of exchange
on which registered
|
Common stock, $1 par value per share
|
|
PKI
|
|
The New York Stock Exchange
|
1.875% Notes due 2026
|
|
PKI 21A
|
|
The New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
At the annual meeting of shareholders of the Company held on April 27, 2021, the shareholders voted on the following proposals:
|
•
|
|
a proposal to elect the eight nominees for director named below for terms of one year each;
|
|
•
|
|
a proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the current fiscal year; and
|
|
•
|
|
a proposal to approve, by non-binding advisory vote, the Company’s executive compensation.
|
The shareholders elected each of the nominees to serve as a director for a term of one year. The final number of votes cast for or against or abstaining and the number of broker non-votes for each nominee are listed below. The proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm, and the proposal to approve, by non-binding advisory vote, the Company’s executive compensation, were each also approved. The final number of votes cast for or against or abstaining from voting on those two proposals and the number of broker non-votes on the executive compensation proposal are listed below.
Proposal #1 – To elect the following nominees as our directors for terms of one year each:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Votes in Favor
|
|
|
Votes Against
|
|
|
Abstentions
|
|
|
Broker Non-Votes
|
|
Peter Barrett, PhD
|
|
|
93,160,674
|
|
|
|
1,780,212
|
|
|
|
52,259
|
|
|
|
6,312,906
|
|
Samuel R. Chapin
|
|
|
94,040,969
|
|
|
|
881,479
|
|
|
|
70,697
|
|
|
|
6,312,906
|
|
Sylvie Grégoire, PharmD
|
|
|
93,914,792
|
|
|
|
1,019,607
|
|
|
|
58,746
|
|
|
|
6,312,906
|
|
Alexis P. Michas
|
|
|
91,807,573
|
|
|
|
3,137,698
|
|
|
|
47,874
|
|
|
|
6,312,906
|
|
Prahlad R. Singh, PhD
|
|
|
94,770,146
|
|
|
|
176,348
|
|
|
|
46,651
|
|
|
|
6,312,906
|
|
Michael Vounatsos
|
|
|
94,746,478
|
|
|
|
177,156
|
|
|
|
69,511
|
|
|
|
6,312,906
|
|
Frank Witney, PhD
|
|
|
94,279,251
|
|
|
|
645,664
|
|
|
|
68,230
|
|
|
|
6,312,906
|
|
Pascale Witz
|
|
|
93,512,669
|
|
|
|
1,433,229
|
|
|
|
47,247
|
|
|
|
6,312,906
|
|
Proposal #2 – To ratify the selection of Deloitte & Touche LLP as the Company’s independent public accounting firm for the current fiscal year.
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
99,594,596
|
|
1,564,822
|
|
146,633
|
|
0
|
Proposal #3 – To approve, by non-binding advisory vote, the Company’s executive compensation.
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
89,990,259
|
|
4,856,614
|
|
146,272
|
|
6,312,906
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
PERKINELMER, INC.
|
|
|
|
|
Date: April 30, 2021
|
|
|
|
|
|
By: /s/ John L. Healy
|
|
|
|
|
|
|
|
|
|
|
John L. Healy
|
|
|
|
|
|
|
|
|
|
|
Vice President and Assistant Secretary
|
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Aug 2024 to Sep 2024
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Sep 2023 to Sep 2024